HealthDay News — The US Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a ...

The randomized trial was conducted in 14 emergency departments and intensive care units in the US involving critically ill adults who were undergoing tracheal intubation. HealthDay News — Use of ...

Fesilty is supplied as a lyophilized powder for reconstitution in a single-dose vial containing approximately 1g of human fibrinogen.

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.

Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

Bisphosphonates may reduce pain intensity in short term, but may result in little to no difference in immediate and medium term.

Andexxa is a recombinant modified human factor Xa protein that received accelerated approval in 2018 for reversal of anticoagulation with rivaroxaban or apixaban due to life-threatening or ...

HealthDay News — The proportion of newborns not receiving intramuscular vitamin K increased from 2017 to 2024, according to a research letter published online December 8 in the Journal of the American ...

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

HealthDay News — Flu season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

The FDA said retailers were first notified of the recall November 8, after health officials determined the formula was the likely source of the outbreak. The company expanded the recall to all ByHeart ...